Alzheimer's & Dementia·9 SepBaseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's diseaseTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecLongitudinal analysis of cerebellar volume changes across the Alzheimer's disease spectrum: implications for cognitive function and neuropsychiatric symptomsStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecDiabetes mellitus‐induced differential cerebellar volume reduction across Alzheimer's disease trajectoryStudy in peoplePopulationsPaper